References - SPEC114220010016

DOE-SPEC-1142-2001

9.3.

A BeLPT shall be reported as normal if neither 9.2.1 or 9.2.2 is satisfied.

9.4.

If either 9.2.1 or 9.2.2 is satisfied, but not both, then the test shall be reported as

borderline. Further interpretation is required based on a more detailed evaluation of

the test results, usually in combination with repeat testing (see Appendices B and C

for details).

10. REFERENCES

10.1.

Epstein, P.E. et al. Bronchoalveolar lavage of a patient with chronic berylliosis. Ann.

Int. Med. 97:213-l 6, 1982.

10.2.

Kreiss, K. et al. Screening blood test identifies subclinical beryllium disease. J.

Occup. Med. 35:267-74, 1993.

10.3.

Kreiss, K., et al. The epidemiology of beryllium sensitization and disease in nuclear

workers. AM. Rev. Resp. Dis. 148:985-91, 1993.

10.4.

Richeldi L., et al. HLA-DPBl glutamate 69: a genetic marker of beryllium disease.

Science 262:242-244, 1993.

10.5.

Rossman, M.D., et al. Proliferative response of bronchoalveolar lymphocytes to

beryllium. Ann. Int. Med., 108:687-693, 1988.

10.6.

Saltini C., et al. Maintenance of alveolitis in patients with chronic beryllium disease

by beryllium-specific helper T cells. New Engl. J. Med., 320:1103-l 109, 1989.